CORDIS
EU research results

CORDIS

English EN

Personalised In-Silico Cardiology

Project information

Grant agreement ID: 764738

Status

Ongoing project

  • Start date

    1 September 2017

  • End date

    31 August 2021

Funded under:

H2020-EU.1.3.1.

  • Overall budget:

    € 4 000 569,48

  • EU contribution

    € 4 000 569,48

Coordinated by:

KING'S COLLEGE LONDON

United Kingdom

Objective

Improving healthcare systems mandates a shift towards personalised and preventive management of disease. Specifically, the management of cardiovascular diseases has a huge impact on European society in terms of mortality, morbidity and healthcare costs, being responsible for 1.9 million deaths in the EU annually (42% of all deaths) with a total cost of €169 billion.
Advances in computational and simulation technologies now provide us with unparalleled capacity to analyse clinical data in-silico, rendering the vision of an early detection of disease through model-based diagnostic biomarkers, and the design of personalised therapies through predictive models. In-silico methodologies enable the optimization of clinical protocols, from data acquisition to device parameters and intervention choices. In-silico tools also enable the reduction of animal use in the development of novel cardiac therapies and drugs.
PIC is the European ITN that will train the cohort of 15 of the future innovation leaders able to articulate and materialise the vision of a Personalised In-silico Cardiology (PIC). It will address specific challenges originated by cultural and structural barriers between sectors and disciplines, articulating a fluent dialogue and work between clinicians and engineers. Fellows will be exposed to the generation of novel academic ideas, the design of practical solutions that meet actual clinical needs, the translation into industrial products, and the compliance with safety and regulation requirements.
This will be achieved by pooling the expertise of leading experts from 4 academic, 3 industrial and 3 clinical beneficiaries. A highly inter-disciplinary program will be delivered in 4 research work packages, with companies leading two of them. New talent and innovation will be produced through the training in the disciplines of computational cardiac modelling, medical imaging & sensing, and clinical devices & instrumentation.

Coordinator

KING'S COLLEGE LONDON

Address

Strand
Wc2r 2ls London

United Kingdom

Activity type

Higher or Secondary Education Establishments

EU Contribution

€ 819 863,64

Participants (9)

OSLO UNIVERSITETSSYKEHUS HF

Norway

EU Contribution

€ 572 550,48

FEOPS NV

Belgium

EU Contribution

€ 250 560

THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD

United Kingdom

EU Contribution

€ 546 575,76

UNIVERSITEIT MAASTRICHT

Netherlands

EU Contribution

€ 510 748,56

UNIVERSIDAD DE ZARAGOZA

Spain

EU Contribution

€ 247 872,96

UNIVERSITE DE BORDEAUX

France

EU Contribution

€ 262 875,60

CONSORCI INSTITUT D'INVESTIGACIONS BIOMEDIQUES AUGUST PI I SUNYER

Spain

EU Contribution

€ 247 872,96

GE VINGMED ULTRASOUND AS

Norway

EU Contribution

€ 286 275,24

MEDTRONIC BAKKEN RESEARCH CENTER B.V.

Netherlands

EU Contribution

€ 255 374,28

Partners (9)

Said Business School

United Kingdom

Food & Drug Administration

United States

CARDIACCS AS

Norway

IBM

United States

Agency for Health Quality & Assessment of Catalonia

Spain

JANSSEN PHARMACEUTICA NV

Belgium

John Radcliffe Hospital

United Kingdom

MS Start

Switzerland

VPH-Institute

Belgium

Project information

Grant agreement ID: 764738

Status

Ongoing project

  • Start date

    1 September 2017

  • End date

    31 August 2021

Funded under:

H2020-EU.1.3.1.

  • Overall budget:

    € 4 000 569,48

  • EU contribution

    € 4 000 569,48

Coordinated by:

KING'S COLLEGE LONDON

United Kingdom